To further examine this hypothesis in prostate cancer cell models, we found that PC3, NCIH660, VCAP, and 22RV1 expressed CDC20 and GSDME at high levels with dataset from CCLE (Fig. 3A). The gene discussed is CDC20; the disease is prostate carcinoma.